As of 2024-12-13, the Fair Value of Eiger BioPharmaceuticals Inc (EIGR) is -339.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.50 USD, the upside of Eiger BioPharmaceuticals Inc is -4,091.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -70.25 | -65.05 | -33.92 | -96.78 | -74.96 | -68.19 |
| YoY growth | -34.09% | 7.40% | 47.86% | -185.32% | 22.54% | -28.32% |
| Market Cap (mil) | 3.03 |
| P/E | |
| Forward P/E |
| EPS | -67.86 |
| Avg earnings growth rate | -28.32% |
| TTM earnings | -74.96 |